On November 20, 2025, AnaptysBio, Inc. filed a complaint against TESARO, Inc. for breaching their Collaboration Agreement, requesting the court's declaration on their rights and remedies. AnaptysBio claims TESARO violated exclusivity terms by participating in competing clinical trials and failed to promote their product, Jemperli, adequately.